MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517014768 A) filed by Aimed Bio Inc., Seoul, Republic of Korea, on Feb. 20, for 'anti-ror1 antibody and use thereof.'
Inventor(s) include Min, Byeongkwi; Yoo, Minyoung; Kim, Jiwon; and Kim, Jongbin.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to: a receptor tyrosine kinase like orphan receptor 1 (ROR 1) antibody or an antigen-binding fragment thereof; a nucleic acid encoding same; a recombinant expression vector carrying the nucleic acid; a host cell transinfected with the recombinant expression vector; a method ...